Bullboard - Stock Discussion Forum Corbus Pharmaceuticals Holdings Inc CRBP

Healthcare Biotechnology

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks... see more

Add To Watchlist

NDAQ:CRBP - Post Discussion

Corbus Pharmaceuticals Holdings Inc > Corbus Pharmaceuticals Announces Closing of $94.5 Million Pu

View:

Post by whytestocks on Feb 02, 2024 7:00pm

Corbus Pharmaceuticals Announces Closing of $94.5 Million Pu

News; $CRBP Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional SharesNORWOOD, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced the closing of its public offering of 4,973,750 shares of its ...CRBP - Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares